PetMed Express, Inc. fell 12.0% on Wednesday, November 11, 2026, on 403,347 shares, 3.3 times its average daily volume. Headlines around the move:
PetMed Express, Inc. (PETS:NASDAQ) closed at $0.940 on November 13, 2026, down 4.96% on the day. The stock trades 77.1% below its 52-week high of $4.10 and 1.1% above its 52-week low of $0.930. Over the past year, it lost 53.0%. PetMed Express, Inc. is part of the Health Care sector (Medical/Nursing Services).
In 252 trading sessions since November 13, 2025, PETS closed higher on 86 days (34%). Its best day was December 11, 2025 (+68.36%) and its worst was November 13, 2025 (-32.41%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 3 times.
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. It provides non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies through its Website. It markets its products through Internet; telephone contact center; and direct mail/print through 1-800-PetMeds catalogs, brochures, and postcards under various brands, including Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution, and Rimadyl. PetMed Express, Inc. was founded in 1996 and is headquartered in Pompano Beach, Florida.
Find more stocks like PETS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.